Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 2020

View Archived Issues

PharmAbcine partners with Thermo Fisher to advance PMC-309

New liver metastasis biomarker and target identified

Y220X mutations impairing the thermostability of p53 can be targeted with small-molecule stabilizers

Cullinan Oncology and PDI Therapeutics collaborate to develop CLN-619

Macrophages rewire cholesterol metabolism for bacterial toxin defense

Optimized tandem CD19/CD20 CAR-engineered T cells induce durable antitumor response

First-in-human data for FP-1305

Boehringer Ingelheim reveals phase I data for BI-836880 plus BI-754091 in NSCLC

Janus kinase inhibitors patented by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology describe IDO-1 inhibitors

RORC antagonists presented by Jiangsu Chia Tai Tianqing Pharmaceutical, Nanjing Gear Pharma & Tech

Harvard College and Zikani Therapeutics identify new azaketolides

Roche presents DNA gyrase and/or DNA topoisomerase IV inhibitors

MDM2 inhibitor KRT-232 shows promise in phase II study in myelofibrosis patients

Initial phase I data show promise for PKCbeta inhibitor MS-553 in R/R CLL/SLL

Sinovac releases preliminary phase I/II results for CoronaVac

ILT-101 expands and activates regulatory T cells in autoimmune/inflammatory diseases

Seattle Genetics opens enrollment in phase I study of SGN-B6A for advanced solid tumors

Carsgen initiates phase I study of AB-011 in CLDN18.2-positive advanced solid tumors

New phase I study of KRAS peptide vaccine in colorectal and pancreatic cancer

Zai Lab studies anti-CD47 antibody ZL-1201 for advanced cancer in phase I

FDA approves dispersible tablet formulation of dolutegravir for infants and children with HIV

Novartis studies MAS-825 in phase II for COVID-19

FDA approves Gardasil 9 for HPV-related oropharyngeal and head and neck cancers

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...